Taiwan FDA registration e5adb43f1d3b6682605d19c4d3576005
Abbott Clinical Chemistry Aspartate Aminotransferase2
TW: 亞培臨床生化第二代天門冬氨酸轉胺酶檢驗試劑組
Taiwan·Risk Class 2·MD·ABBOTT IRELAND DIAGNOSTICS DIVISION·Registered Sep 21, 2022 – Sep 21, 2027ActiveRegistration details
- Analysis ID
- e5adb43f1d3b6682605d19c4d3576005
- License Form
- Ministry of Health Medical Device Import No. 035855
- Customs Code
- DHA05603585501
Company information
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Manufacturer Country
- Ireland
- Authorized Representative
- ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- This product is used for the quantitative detection of aspartate amino transferase in human serum or plasma on the ARCHITECT c system; AST).
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1100 Aspartine transaminase test system
- Import Information
- Imported from abroad; GMP
Dates and status
- Registration Date
- Sep 21, 2022
- Expiry Date
- Sep 21, 2027
About this record
Access comprehensive regulatory information for Abbott Clinical Chemistry Aspartate Aminotransferase2 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e5adb43f1d3b6682605d19c4d3576005 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices